Catyalyst Pharma (CPRX) Tops Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Price: $31.40 --0%
Revenue Growth %: +5.9%
Financial Fact:
Net loss: -3.95M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Revenue Growth %: +5.9%
Financial Fact:
Net loss: -3.95M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Catyalyst Pharma (NASDAQ: CPRX) reported Q2 EPS of ($0.05), $0.01 better than the analyst estimate of ($0.06).
For earnings history and earnings-related data on Catyalyst Pharma (CPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Paychex beats fourth quarter EPS estimates, stock slides
- Benchmark Reiterates Buy Rating on Cineverse (CNVS) Ahead of Q4 Results
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
